The U.S. cannabis industry is expanding rapidly, with projections suggesting it could surpass $75 billion in value by 2030. This growth is fueled by rising consumer demand, expanding legalization, and increased acceptance of medical cannabis. Recently, lawmakers introduced new legislation that could pave the way for federal cannabis reform. This has reignited investor interest in marijuana-related stocks, especially low-cost options. As the regulatory environment evolves, these penny stocks are drawing attention for their high-reward potential.

Marijuana penny stocks typically trade below $5 per share. They can offer fast gains but also carry elevated risks. Therefore, technical analysis becomes essential. Tools like moving averages and RSI help identify momentum shifts. Traders also watch support and resistance zones for trade setups. Risk management is equally important. Setting stop-loss orders and position sizing are key to protecting capital. In this fast-moving sector, staying disciplined can help turn volatility into opportunity.

The U.S. cannabis industry is expanding rapidly as legalization efforts continue. Investors are turning their attention to marijuana stocks showing strong fundamentals and operational growth. In April 2025, three standout companies include Glass House Brands Inc. (GLASF), Cansortium Inc. (CNTMF), and Ascend Wellness Holdings Inc. (AAWH). Each company offers strategic advantages, growing footprints, and compelling financial stories. With demand for cannabis increasing and regulatory reform underway, these stocks deserve a closer look.

[Read More] 2 Marijuana Stocks To Consider For Long-Term Investing

Top 3 Marijuana Stocks to Watch in April 2025

1. Glass House Brands Inc. (OTC: GLASF)
2. Cansortium Inc. (OTC: CNTMF)
3. Ascend Wellness Holdings Inc. (OTC: AAWH)

Glass House Brands Inc. (GLASF)

Glass House Brands is based in California and focuses on cultivating, manufacturing, and distributing cannabis products. It has become one of the largest vertically integrated cannabis companies in the state. The company emphasizes sustainable, environmentally friendly growing techniques. It owns one of the largest greenhouse operations dedicated to cannabis cultivation in the U.S.

As of April 2025, Glass House operates five dispensaries across California. These locations include cities like Los Angeles, Santa Barbara, and Berkeley. The company targets both wholesale and retail segments, supplying dispensaries and direct consumers alike. Its strong presence in California gives it access to the country’s largest legal cannabis market.

Financially, Glass House continues to show year-over-year growth. In 2024, it significantly increased biomass output, helping drive higher revenue. It projects biomass production to increase by over 25% this year. Additionally, full-year revenue is expected to grow by more than 10%.

Adjusted EBITDA nearly doubled in the most recent quarter. Profit margins also improved due to cost reductions and operational efficiencies. Overall, the company is on track for a profitable year, driven by strategic expansion and production scale. Investors see Glass House as a dominant California brand with national growth potential.

[Read More] April 2025’s Canadian Cannabis Stock Picks: Growth and Opportunity

Cansortium Inc. (CNTMF)

Cansortium Inc. operates under the brand name FLUENT. It is a vertically integrated cannabis company focused on quality cultivation and retail services. The company is headquartered in Miami, Florida, and serves several key U.S. markets. Cansortium is known for its medical cannabis operations and dedication to customer experience.

Its largest footprint is in Florida, where it runs dozens of dispensaries. Additional operations extend into Pennsylvania and Texas. The company focuses on creating consistent, premium cannabis products. As of April 2025, it manages 28 dispensary locations across the country.

Cansortium’s financial performance reflects its disciplined approach. The company has maintained stable operations despite pricing pressures in Florida. While its stock price remains below one dollar, it continues to attract attention for long-term growth. Cost controls and streamlined operations have helped reduce cash burn.

Though revenue has remained relatively flat, gross margins have shown improvement. The company remains committed to profitability, even in a challenging environment. By focusing on core markets and operational efficiency, Cansortium aims to return to growth in the second half of the year.

[Read More] Top Ancillary Marijuana Stocks For The Diversified Investors

Ascend Wellness Holdings Inc. (AAWH)

Ascend Wellness is a multi-state operator with assets across several eastern U.S. states. The company is based in New York and holds cultivation, processing, and retail licenses. Its markets include Illinois, Michigan, New Jersey, Massachusetts, Ohio, and Pennsylvania. Ascend targets both adult-use and medical cannabis consumers.

The company currently operates 35 dispensaries and seven cultivation facilities. It has established a strong brand in states like Illinois and New Jersey. Ascend’s vertically integrated model supports supply chain control and higher profit margins. Its premium product lines are sold across retail and wholesale channels.

In 2024, Ascend posted strong financials. Total annual revenue increased to over $560 million, driven by wholesale growth. Third-party wholesale sales surged nearly 30%, supporting top-line expansion. Retail sales held steady, despite market saturation in some states.

Adjusted gross profit reached over $225 million, with margins improving year-over-year. The company ended the year with nearly $90 million in cash, giving it flexibility for future investments. Ascend continues to optimize operations while expanding its geographic footprint. It remains well-positioned for further growth in 2025 and beyond.

Undervalued Cannabis Stocks Ready to Rebound

To begin with, these three companies—Glass House Brands, Cansortium, and Ascend Wellness—each offer a unique value proposition in the evolving cannabis sector. Moreover, their strong operational strategies, expanding footprints, and disciplined financials make them top marijuana stocks to watch in April 2025. As a result, they are well-positioned to benefit from renewed momentum in the industry. Looking ahead, as investor interest returns to cannabis, these names could very well lead the next wave of growth.

The post Top U.S. Pot Stocks for Growth in April 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks could soon see a small boost in momentum. The reason for this could be that although Trump is in office not much has taken place to derail the cannabis industry. Without federal reform in place shareholders and future investors do not want to take such a big risk. Especially with not many of Trump’s people being on board with legal cannabis as is.

Now as things begin to settle and investors observe there have yet to be any big changes it may restore some faith. For instance, as the legal cannabis industry continues to grow and thrive it should be a smoke signal things are ok. But as mentioned above people are just too fearful of waiting and losing money. Yet there are a handful of shareholders that see the finish line down the road as where their prize will be.

The long game is the idea and approach some are taking. People are doing their homework and taking advantage of this downtrend to find top marijuana stocks to buy. Even still nothing is etched in stone but it’s better to be prepared than not. At this time people are watching with caution and bits of hope that things will eventually change. Below are a few marijuana stocks to watch as things progress in the market.

Marijuana Stocks To Watch For Better Trading

1. Verano Holdings Corp. (OTC:VRNOF)
2. Planet 13 Holdings Inc. (OTC:PLNH)
3. Trulieve Cannabis Corp. (OTC:TCNNF)

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. On April 17th the company announced the opening of its new location.

Now Verano has expanded its presence with 81 dispensaries with this storefront. This new location is in New Smyrna Beach FL.

Words From The Company

“We are excited to welcome patients to MÜV New Smyrna Beach as we celebrate the opening of our 81st location during 420 weekend,” said John Tipton, President of the Southern Region.”

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

At the start of April Planet 13 announced the opening of a new dispensary located in Orange Park FL. This makes a total of 32 dispensaries for the company in FL.

[Read More] Top Ancillary Marijuana Stocks For The Diversified Investors

Words From The CEO

“We’re thrilled to open another convenient Planet 13 dispensary, bringing our award-winning products to the growing Florida medical cannabis community,” said Bob Groesbeck, Co-CEO of Planet 13.

[Read More] April 2025’s Canadian Cannabis Stock Picks: Growth and Opportunity

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.

On April 10th the company announced it will hold a Q1 2025 conference call to report earnings for that time. So Trulieve has set May 7th at 8:30 AM as the date and time of the call.

The post 2 Marijuana Stocks To Consider For Long-Term Investing appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

As the U.S. cannabis industry continues to grow, Canadian cannabis stocks are gaining momentum with investors. The U.S. market is expected to reach over $44 billion in 2025. By 2030, analysts believe it could climb to more than $75 billion. Adult-use cannabis is now legal in nearly half of the U.S. states. Many others permit medical use, creating widespread demand. At the same time, lawmakers are again discussing federal reform bills. These bills aim to provide national guidelines and unlock interstate trade. Although legalization has faced delays, investor sentiment remains optimistic. Canadian companies are preparing to scale their U.S. operations once laws change.

For those watching cannabis stocks, technical analysis and strong risk management are essential. Traders should track price levels, trend strength, and buying volume. Support and resistance zones can guide entry and exit decisions. Meanwhile, risk management helps prevent emotional trading and limits downside exposure. As the sector remains volatile, discipline is key. With careful planning, investors can position for future upside while protecting capital.

Investors are increasingly watching these firms for their strategic U.S. expansions, unique product lines, and financial recovery efforts. Tilray Brands (TLRY), Canopy Growth Corporation (CGC), and Village Farms International (VFF) are three top Canadian cannabis stocks showing potential in April 2025. Despite ongoing regulatory hurdles, each has developed a growing footprint in the American market. Let’s break down where each company stands and how its financials are shaping up.

[Read More] Top Ancillary Marijuana Stocks For The Diversified Investors

Top 3 Canadian Cannabis Stocks to Watch in April 2025

Tilray Brands (NASDAQ: TLRY)

Canopy Growth Corporation (NASDAQ: CGC)

Village Farms International (NASDAQ: VFF)

Tilray Brands (TLRY)

Tilray Brands remains one of Canada’s most well-known cannabis companies. It operates in the cannabis, hemp, and craft beverage sectors. Although Tilray is headquartered in Canada, it has carved out a strong presence in the U.S. through acquisitions. These include SweetWater Brewing and Manitoba Harvest, which distribute across many U.S. states. As of now, Tilray does not run any dispensaries in the United States. Instead, it uses indirect methods to expand reach, such as beverages and hemp-based wellness products. This allows Tilray to build brand familiarity while awaiting full federal legalization. Additionally, Tilray is positioning itself for fast entry once regulatory barriers are lifted. These strategic moves help it stay competitive and build U.S. infrastructure ahead of time.

Latest Financials

In its most recent quarter, Tilray reported net revenue of approximately $186 million. This figure slightly decreased compared to last year’s same quarter. However, gross profit rose year-over-year to just over $52 million. Tilray’s cannabis business contributed about 29% of the total revenue. Beverage products—like THC-free craft beer—contributed a similar share. The company still posted a significant quarterly loss, largely due to non-cash impairment charges. Tilray continues to focus on restructuring costs and optimizing operations. It remains committed to growing revenue through high-margin segments. The path to profitability may be long, but Tilray appears determined to stabilize and scale up across both North American and global markets.

[Read More] Best Cannabis Infrastructure Stocks to Buy in 2025

Canopy Growth Corporation (CGC)

Canopy Growth has gone through multiple transitions in recent years. It is now shifting its focus toward U.S. cannabis expansion. The company owns recognizable brands such as Tweed and 7ACRES. However, Canopy has made bigger waves through U.S. acquisitions. These include Acreage Holdings, Wana Brands, and Jetty Extracts. These moves give Canopy a foothold in several states, including New York, New Jersey, and Illinois. Through Acreage, Canopy gains access to a dispensary network and cultivation licenses. Although full control remains conditional on U.S. federal reform, Canopy has positioned itself as a first-mover. This strategy allows it to build value while waiting for regulatory green lights. The company also has a wellness and vape presence in various U.S. markets.

Latest Financials

For the latest quarter, Canopy Growth reported around $75 million in net revenue. This was a slight decline year-over-year, reflecting headwinds in Canadian adult-use sales. Gross margins came in at roughly 32%, slightly below previous levels. The company continues to invest in high-growth segments like international medical cannabis and U.S. wellness products. Medical sales in Canada grew, while international exports showed modest gains. Despite these improvements, Canopy posted a large quarterly loss due to restructuring and overhead. Management has responded by cutting costs and repaying over $100 million in debt early. This will reduce annual interest expenses going forward. The goal is to improve cash flow and streamline operations ahead of a possible U.S. legalization breakthrough.

[Read More] Top U.S. Marijuana Stocks to Watch Now for a Potential Recovery

Village Farms International (VFF)

Village Farms began as a large-scale vegetable grower. However, it has since evolved into a leading low-cost cannabis producer. Its Canadian operations are managed under Pure Sunfarms, one of the country’s most profitable growers. In the U.S., the company sells hemp-derived wellness products through Balanced Health Botanicals. Although it does not operate dispensaries in the U.S., it has a strong online retail footprint. Village Farms also recently began expanding into Europe through the Netherlands. There, it is developing a commercial cannabis facility targeting the growing European market. With these multi-national efforts, the company is steadily growing its brand beyond Canada.

Latest Financials

Village Farms posted quarterly revenue of roughly $83 million, showing steady growth from prior quarters. On a full-year basis, sales totaled over $336 million. This represented solid double-digit growth year-over-year. The Canadian cannabis division led the way, with flower sales rising significantly. However, the company did record a write-down of about $10 million on older inventory. This impacted profitability, though it was a non-cash event. Adjusted EBITDA was positive, helped by cost efficiencies and scale. Village Farms also generated over $10 million in positive operating cash flow. Despite challenges, the company received a Nasdaq extension to comply with minimum bid requirements. It continues to pursue cost controls while scaling up internationally. With improving fundamentals and exposure to both the U.S. and European markets, Village Farms is emerging as a long-term contender.

Investing in Growth: Canada’s Cannabis Market Leaders

These three Canadian cannabis companies are well worth watching in April 2025. Each has unique strategies for breaking into the U.S. market despite ongoing federal restrictions. Tilray focuses on beverages and distribution. Canopy leverages strategic acquisitions. Village Farms prioritizes profitability and international growth. Their financials reflect early recovery signs, though risks remain. Investors should continue monitoring quarterly earnings, debt levels, and U.S. legalization news. As the industry stabilizes, these names could offer strong upside potential for patient, risk-aware investors.

The post April 2025’s Canadian Cannabis Stock Picks: Growth and Opportunity appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

What is going to happen to marijuana stock and when will the sector bounce? This is the long-standing question and roadblock for many who hold shares of cannabis stocks. With the current political climate in the USA, it is not easy to have strong convictions of positive market outcomes. To further explain it is not that volatile pops can not happen as that is happening now. But with many issues in the way for investors and legal operators, it impacts the public sector in such a way.

There have been some who watch marijuana stocks in hopes of catching a small bounce. The levels of trading are often not as high as they should be and they are short-lived. The hope is that continued industry success and more efficient laws in place will help to bring all marijuana stocks up in share price. The speculation is if there is a safer structure in place for the industry then investors will feel safer to potentially put more money into the public sector.

However, some ancillary cannabis stocks have been able to see strong trading. Mainly due to their business not solely relying on cannabis. So investors see it as a company not directly involved and as mentioned above a safer bet while still taking part in the sector. The more you can diversify the better the odds of seeing more profits while shareholders wait for the bulk of pot stocks to rise once more.

Top Marijuana Stocks For Your List 2025

1. Leafly Holdings, Inc. (OTC:LFLY)
2. WM Technology, Inc.(NASDAQ:MAPS)
3. High Tide Inc. (NASDAQ:HITI)

Leafly Holdings, Inc.

Leafly Holdings, Inc. operates as an online cannabis discovery marketplace and resource in the United States and internationally. It operates through the Retail and Brands segments. 

During the 2nd week of January 2025, the company announced the receipt of notice of delisting from the Nasdaq. Now LFLY Stock will be traded on the OTC market. This was due to the Company’s failure to comply with the minimum $500,000 in net income from continuing operations.

WM Technology, Inc.

WM Technology, Inc., an online cannabis marketplace, provides e-commerce and compliance software solutions to retailers and brands in the cannabis market in the United States and internationally. On March 13th, 2025, the company reported its Q4 and full 2024 year financial report.

Fourth Quarter 2024 Financial Highlights

• Revenue of $47.7 million increased from $46.6 million in the prior quarter and $46.5 million in the prior year period.
• Net income decreased to $3.7 million from $5.3 million in the prior quarter and increased from net loss of $11.2 million in the prior year period.
• Adjusted EBITDA(3) increased to $11.9 million from $11.3 million in the prior quarter and $8.9 million in the prior year period.
• Fiscal Year 2024 Financial Highlights
• Revenue of $184.5 million decreased from $188.0 million in the prior year.
• Net income increased to $12.2 million from net loss of $15.7 million in the prior year.
• Adjusted EBITDA(3) increased to $42.9 million from $36.9 million in the prior year.

[Read More] Best Cannabis Infrastructure Stocks to Buy in 2025

High Tide Inc.

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. It operates through Bricks and Mortar Operations; and E-commerce Operations segments.

In recent news, the company announced the opening of its Canna Cabana retail cannabis store set to open April 16th, 2025. This opening brings High Tide’s total store count to 195 Canna Cabana branded retail cannabis locations across Canada.

[Read More] 3 Canadian Marijuana Stocks That Could See Big Future Gains

Words From The CEO

“This latest store opening in Kitchener, Ontario reflects our continued commitment to disciplined growth, even as we navigate an evolving macroeconomic environment. In light of the recently announced tariff actions by the United States, we want to reassure our investors that the vast majority of our revenue is generated from products procured and sold within Canada.”

The post Top Ancillary Marijuana Stocks For The Diversified Investors appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success.

The public sector is not seeing anything transfer over that would show investors that they can have the confidence to trade. With Donald Trump in office, many investors and legal operators feel unsafe and even more uncertain about what will unfold. But some feel things have progressed too far for any type of halt in the legal cannabis market around the USA.

Trump has even gone on record to say he feels that states should have the right to vote and set up procedures for new markets. These people who are more on the glass half full about legal cannabis see the long game as the way to go. Right now it is still too volatile and people are still measuring all the possibilities and potential industry outcomes. It is always a good idea to learn more about what is going on in the sector so you can stay in the know about what could happen as a marijuana stock investor.

Marijuana Stocks To Know About 2025

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Cronos Group Inc. (NASDAQ:CRON)
3. Aurora Cannabis Inc. (NASDAQ:ACB)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

In the most recent news, Tilray has come in as number 4 on the Brewers Association 2024 annual report. Specifically for the top 50 craft brewing companies in the USA. This marks a notable rise from its previous position at #5, reflecting the company’s continued growth and success in the craft brewing industry.

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

It has been some time since the company has a new company update. Back in March 2025, the company announced the appointment of Anna Shlimak as Chief Financial Officer. Ms. Shlimak has been an integral part of Cronos’ leadership team for the last seven years.

Words From The Company

“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos.”

[Read More] Top U.S. Marijuana Stocks to Watch Now for a Potential Recovery

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

In recent news the company introduces the first inhalable resin cartridges. This product is for patients in the United Kingdom. These products are available to patients in Canada and Australia.

[Read More] 3 Marijuana Stocks To Buy Now And Sell When The Sectors Up

Words From The Managing Director Aurora UK and Ireland

“As a company dedicated to patient care and ensuring we regularly listen to patient feedback – we recognized a real need for a convenient, and discreet consumption option and are excited to introduce a new cannabis format at a promised level of quality,” said Trisha Cassidy.

The post 3 Canadian Marijuana Stocks That Could See Big Future Gains appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis market continues to expand rapidly, with expected revenues reaching over $45 billion by 2025. This growth is fueled by rising consumer demand and ongoing state-level legalization. So far, 24 states and Washington, D.C. have legalized adult-use marijuana. Nearly 80% of Americans now live near a dispensary. Although federal reform has faced challenges, momentum continues to build. Most recently, a major legalization proposal in Florida failed to meet the required 60% threshold. However, efforts remain active across other key states. Many investors are now focused on the DEA’s expected rescheduling of cannabis. This move could reduce tax burdens and increase medical research. With this news circulating, top marijuana stocks are showing renewed volatility and opportunity this week.

With market sentiment shifting, traders must stay focused and disciplined. Technical analysis is critical when identifying price trends, breakouts, and support zones. In addition, traders should use stop-loss orders to protect against downside risk. Volatility remains high across cannabis names, so managing position size is essential. When evaluating marijuana stocks, it helps to track volume, recent news, and price structure. Watching how a stock reacts at key levels gives insight into trader sentiment. Moreover, staying updated on federal reform talks can provide early clues for breakout potential. While long-term growth is strong, short-term moves can be fast and unpredictable. By combining risk management with clear trade planning, investors can better capture gains while avoiding steep losses.

The Future of the Cannabis Industry

With legalization efforts gaining momentum, multi-state operators are positioned for significant growth. Among the top stocks to watch this month are Trulieve Cannabis Corp. (TCNNF), Curaleaf Holdings Inc. (CURLF), and Verano Holdings Corp. (VRNOF). These companies offer wide dispensary coverage, steady financials, and long-term potential. Additionally, investors should use technical analysis and solid risk management strategies when entering positions.

While recent pullbacks have created attractive entry points, traders must remain disciplined. Support and resistance levels should be closely monitored to identify key price action. By focusing on cannabis leaders with proven performance and strong cash flows, investors can position themselves ahead of possible policy shifts. Let’s take a closer look at three U.S. marijuana stocks to watch this April.

[Read More] 3 Marijuana Stocks To Buy Now And Sell When The Sectors Up

Top 3 U.S. Marijuana Stocks to Watch in April 2025

1. Trulieve Cannabis Corp. (OTC: TCNNF)
2. Curaleaf Holdings Inc. (OTC: CURLF)
3. Verano Holdings Corp. (OTC: VRNOF)

Trulieve Cannabis Corp. (TCNNF)

Trulieve Cannabis Corp. is a top multi-state operator based in Florida. It has built a dominant footprint across the Southeast. The company’s largest presence is in Florida, where it holds a leading market share. Trulieve also operates in states such as Pennsylvania, Arizona, and Ohio. As of early 2025, Trulieve manages 225 dispensaries across the U.S. The company continues to open new locations as adult-use markets expand. Trulieve recently launched adult-use operations in Ohio and expects more openings in 2025. Its strong retail network helps maintain its customer base and brand recognition. Trulieve’s commitment to growth keeps it ahead of smaller competitors. Its vertical integration strategy also allows for better control over quality and costs. This gives the company a competitive advantage in tight-margin markets. Overall, Trulieve remains a key player in U.S. cannabis retail and production.

Financial Performance

Trulieve reported revenue of $1.2 billion in 2024. This marked a 5% increase from the previous year. The company maintained a gross margin of 60%, signaling efficient cost management. Its adjusted EBITDA reached $420 million, or 35% of total revenue. This shows strong profitability despite pricing pressure across the industry. Trulieve also delivered $271 million in operating cash flow. Free cash flow came in at $150 million. These strong cash flows give the company financial flexibility. Trulieve continues to reduce debt while investing in growth. Capital discipline and cash generation are key strengths. The company is also exploring strategic acquisitions in emerging markets. These financial results show that Trulieve is well-positioned for future growth. Even with regulatory delays, the company’s fundamentals remain solid. Investors looking for strong cannabis stocks with profitability and scale should consider Trulieve this month.

[Read More] 2 Canadian Marijuana Stocks For Your Upcoming Watchlist

Curaleaf Holdings Inc. (CURLF)

Curaleaf Holdings Inc. is one of the largest cannabis companies in the U.S. The company is headquartered in Massachusetts and operates across 17 states. Its largest retail presence is in states like Florida, Arizona, and New Jersey. As of 2025, Curaleaf operates 151 dispensaries nationwide. It also owns 19 cultivation facilities, making it a fully integrated operator. Curaleaf focuses on high-growth, heavily populated markets. This gives it access to a wide customer base and strong brand exposure. The company continues to expand into new adult-use states. It is also positioning itself to benefit from possible federal reform. In 2024, Curaleaf strengthened its retail footprint and refined its product lines. It continues to launch new wellness and THC-infused products across the country. Overall, Curaleaf remains a market leader with national exposure and steady growth plans. It is one of the few cannabis companies with the scale to compete long-term.

Financial Performance

Curaleaf reported $1.34 billion in revenue for 2024. This made it one of the highest-grossing cannabis companies in the U.S. Its gross profit was $639 million, with a gross margin of 48%. Adjusted EBITDA came in at $75 million, with a 23% EBITDA margin. While the company posted a net loss of $71 million, it also reported an adjusted net income of $12 million. Curaleaf held $107 million in cash at year-end. This gives it the liquidity needed for continued expansion. The company remains focused on cost reduction and margin improvement. It has exited underperforming markets and is reallocating resources. Its financials show a commitment to streamlining operations and protecting shareholder value. Despite short-term losses, Curaleaf’s top-line growth and cash reserves support its long-term thesis. Investors should watch for margin expansion and operational updates in 2025.

[Read More] Marijuana Stocks in Focus: U.S. Companies Ready for a Breakout

Verano Holdings Corp. (VRNOF)

Verano Holdings Corp. is based in Illinois and is one of the fastest-growing multi-state cannabis operators. The company focuses on high-margin, high-growth adult-use and medical markets. Verano operates in 13 states, including Illinois, New Jersey, and Florida. Its largest presence is in Illinois, where it operates a strong retail and cultivation footprint. Verano has over 135 dispensaries and continues to grow through both organic expansion and acquisitions. In 2024, Verano opened several new stores and launched branded products across multiple markets. The company’s strategy emphasizes premium flower, edibles, and wellness-based cannabis. It also integrates technology into its retail experience to boost customer loyalty. With growing market share and product innovation, Verano is well-positioned for future industry consolidation. Investors are watching Verano’s ability to scale while maintaining product quality and brand value.

Financial Performance

Verano reported $879 million in revenue for 2024, which represented a 6% decline year-over-year. Despite the revenue dip, the company maintained strong gross margins of 51%. Verano’s adjusted EBITDA was $264 million, or 30% of total revenue. The company posted a net loss of $342 million, which included non-cash impairment charges. However, Verano generated $112 million in cash from operations. This allowed it to invest $99 million in capital expenditures. The company focused on infrastructure, cultivation upgrades, and store expansion. Verano’s strong EBITDA margins and positive cash flow remain key strengths. While net losses are a concern, they are mainly non-operational. Management is focused on improving cash efficiency and scaling its retail network. Verano remains an attractive pick for investors looking for a balance of growth and margin stability.

Best Marijuana Stocks for a Potential Upswing This Year

These three U.S. cannabis leaders—Trulieve, Curaleaf, and Verano—offer broad retail footprints, solid financials, and long-term potential. In a shifting regulatory environment, scale and efficiency are vital. Investors should continue to monitor these names for bullish technical setups and use proper risk management before entering trades.

The post Top U.S. Marijuana Stocks to Watch Now for a Potential Recovery appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks are torn between two ferns, and this has created a volatile frenzy in the sector. It could be that people feel the cannabis sector will eventually take the behavior of other sectors when in a less volatile space. Uncertainty brings lots of fears doubts, and caution on how to proceed in the future. Now with tariffs in place with China, packaging and other logistics concerns for businesses could lead to deeper issues and problems.

All of the above plays a big part in how investors will react, often leading to no trading or a sell-off. Either way, it brings the share price of most cannabis stocks down. However, the idea and hope is that more progress and success for legal operators will keep investors intrigued. Right now, even in a down market, is the moment to plan and strategize. The cannabis industry overall has been growing in all sectors. This is why the future of investing could be where another green rush moment can occur.

Many top companies are trading lower than normal share prices. This makes finding the best marijuana stocks to buy more exciting and affordable. The long-term play is where the mindset is for most pot stock investors. If you look below, there are a few marijuana stocks to watch that could be companies to possibly add to the portfolio.

Top Marijuana Stocks To Watch 2025

1. High Tide Inc. (NASDAQ:HITI)
2. Cronos Group Inc.(NASDAQ:CRON)

High Tide Inc.

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. It operates through Bricks and Mortar Operations; and E-commerce Operations segments. The company recently announced the opening of a new Canna Cabana store located in in Kitchener, Ontario. The  Kitchener, Ontario will begin selling recreational cannabis products and consumption accessories for adult use on April 16, 2025.

[Read More] 3 Canadian Marijuana Stocks For Long-Term Investing

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. Back in mid-March of 2025, the company announced AnnaShlimak as the new Chief Financial Officer.

Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm. Ms. Shlimak has been an integral part of Cronos’ leadership team for the last seven years, playing a key role in shaping the Company’s strategy.

[Read More] Top Cannabis Stocks In The Public Sector 2025

Words From The Company

“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos. “Anna has been an essential part of our senior leadership team.”

The post 2 Canadian Marijuana Stocks For Your Upcoming Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

As the tariffs are set in place, it will probably create a ripple effect throughout the cannabis industry. This may impact things from production costs to market prices. Even how marijuana stocks trade, although the sector has been down for some time. As tariffs are implemented, import costs for materials needed in cannabis, such as hydroponic systems, lighting equipment, and other growing supplies, may increase.

This increase could lead to higher operational costs for cannabis farmers. Increased operation costs may put operators in a position to charge more for cannabis goods in response to the higher prices for cannabis products. From an investment perspective, top marijuana stocks may react poorly to these changes. Yet, investors are assessing the potential for a future turnaround in trading.

With how low the sector has been performing finding top Marijana stocks to buy at lower shares is still possible. The idea is to see what will come and hope to see a stronger industry and more success down the line. Which is the speculation many cannabis stock shareholders have. They are planning for the future as this is where they see the silver lining to all that is happening. The marijuana stocks to watch mentioned below could be a few options to consider during this time.

Marijuana Stocks To Watch In Volatile Sector

1. Green Thumb Industries Inc. (OTC:GTBIF)
2. Greenlane Holdings, Inc. (NASDAQ:GNLN)

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. 

In recent news, the company has announced it will hold a Q1 2025 earnings conference call. May 7th is the date that Green Thumb has selected for this call to take place.

[Read More] This Is How The Tariffs Will Impact Marijuana Stocks In 2025

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. engages in the development and distribution of cannabis accessories, vape devices, and lifestyle products in the United States, Canada, and Europe. It operates in two segments, Consumer Goods and Industrial Goods.

At the end of March, the company announced it would join the Mainstem B2B procurement marketplace platform. MainStem offers an end-to-end, enterprise-level supply chain solution designed to streamline procurement for the legal cannabis industry.

[Read More] April 2025 Watchlist: Best Ancillary Cannabis Stocks for Growth Potential

Words From The Company

“At Greenlane, our strategy is to deliver quality, a diverse selection of cannabis and wellness products, and value for our customers,” said Barbara Sher, Chief Executive Officer for Greenlane.”

The post 2 Marijuana Stocks To Watch In An Uncertain Time appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to show impressive growth, making marijuana penny stocks a hot topic for investors this week. In 2024, legal cannabis sales reached over $32 billion across the country. That number is expected to grow past $50 billion by the end of 2025. Many states are expanding access to both medical and recreational marijuana, helping fuel this rapid expansion. In addition, recent discussions around federal reform have renewed optimism. There are growing calls to reschedule cannabis to reflect its medical use. If changes happen, they could unlock major opportunities in the market. Because of this momentum, many investors are turning their attention to low-cost marijuana stocks with high potential.

However, investing in penny stocks requires a disciplined and cautious approach. These stocks are highly volatile and can shift quickly in price. Using technical analysis can help identify strong setups and ideal trade entries. Traders commonly use indicators like moving averages and RSI. But it is equally important to manage risk with each trade. This means setting stop-loss levels, sticking to a budget, and avoiding oversized positions. It also helps to track industry news and price trends for early warning signs. Combined with a solid plan, technical tools, and risk control, it can make trading marijuana penny stocks more manageable.

Cannabis Stocks Making Headlines

As the U.S. cannabis industry grows in 2025, investors are keeping a close eye on several promising marijuana stocks. While federal legalization remains uncertain, many state markets continue to expand. This gives vertically integrated companies room to grow operations and gain market share. In April 2025, three U.S. cannabis companies stand out for their performance and presence—Ayr Wellness Inc. (AYRWF), Ascend Wellness Holdings (AAWH), and The Cannabist Company Holdings Inc. (CBSTF). Each company operates a growing retail network and is positioned to benefit from market developments. With improving balance sheets and disciplined growth strategies, they have become top names to watch this month.

[Read More] This Is How The Tariffs Will Impact Marijuana Stocks In 2025

Top U.S. Marijuana Stocks to Watch Right Now for Growth Potential

1. Ayr Wellness Inc. (OTC: AYRWF)
2. Ascend Wellness Holdings (OTC: AAWH)
3. The Cannabist Company Holdings Inc. (OTC: CBSTF)

Ayr Wellness Inc. (AYRWF)

Ayr Wellness is a vertically integrated cannabis operator with a strong presence in multiple U.S. markets. The company’s largest footprint is in Florida, where it operates 67 dispensaries across the state. Ayr is also active in states like Pennsylvania, Ohio, and Connecticut, giving it a diverse presence. The company serves both medical and adult-use cannabis markets, focusing on premium products and in-house cultivation. Over the past year, Ayr has worked to strengthen its operations by closing underperforming stores and focusing on higher-margin assets. Its goal is to increase efficiency and return to consistent profitability. The company’s brand portfolio includes offerings across several categories, from edibles to concentrates.

In its most recent earnings report, Ayr posted quarterly revenue of $114 million. The company’s gross margin was 49%, showing improved operational efficiency. Adjusted EBITDA reached $19.1 million, marking a stable performance in a competitive market. Ayr also reported $10 million in cash flow from operations, which supports its efforts to reduce debt. The company ended the period with $35 million in cash, offering some financial flexibility. Despite continued industry headwinds, management is focused on sustainable growth and cost control. If markets stabilize, Ayr could see further upside from its streamlined operations and broad state footprint.

[Read More] April 2025 Watchlist: Leading Cannabis Stocks from Canada

Ascend Wellness Holdings (AAWH)

Ascend Wellness is another vertically integrated cannabis operator with a strong retail and wholesale presence. The company’s largest operations are in Illinois and Michigan, two of the most active cannabis markets in the Midwest. Ascend operates 36 dispensaries and continues to add locations in high-demand areas. It also maintains cultivation and production facilities to support its branded product lines. The company targets both recreational and medical consumers, with a focus on premium products. Ascend has steadily grown its market share by entering limited-license states and acquiring assets in key regions. Its strategy is based on disciplined expansion and operational efficiency.

Ascend recently reported full-year revenue of $561.6 million, showing solid year-over-year growth. Gross profit reached $184.2 million, with a gross margin of nearly 33%. Adjusted EBITDA came in at $116 million, reflecting a healthy 9% annual gain. The company ended the year with $88 million in cash, giving it a strong balance sheet. This cash position allows for continued expansion and potential debt reduction. Ascend has focused on streamlining operations and improving store-level profitability. Despite regulatory delays and margin pressure across the sector, it continues to show resilience. Investors may see more upside as the company refines operations and expands its store base.

[Read More] April 2025 Watchlist: Best Ancillary Cannabis Stocks for Growth Potential

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company, formerly known as Columbia Care, is one of the oldest licensed cannabis operators in the U.S. It has a wide national footprint, holding licenses in 14 states. The company operates 70 dispensaries and runs 19 cultivation and processing facilities. Its largest markets include New York, Virginia, and Florida. The Cannabist brand focuses on both medical and adult-use customers, offering products across all major cannabis categories. The company has spent the past year rebranding, improving customer experience, and divesting non-core assets. These moves are designed to improve profitability and focus on high-performing markets.

The Cannabist Company recently reported revenue of $114.8 million for the quarter, slightly down from previous levels. However, gross profit rose to $43.8 million, reflecting better cost controls. The company narrowed its net loss to just $1.8 million, showing significant improvement from prior quarters. Over the last few months, it sold non-core assets and raised $105 million, which improved its cash position. The company ended the quarter with $31.5 million in cash and plans to continue optimizing its portfolio. Management remains focused on reducing debt, improving margins, and expanding in high-growth states. With a leaner and more focused structure, The Cannabist Company is rebuilding investor confidence.

U.S. Cannabis Stocks Poised for Growth in the Current Market Cycle

Each of these three companies—Ayr Wellness, Ascend Wellness, and The Cannabist Company—has navigated the cannabis market’s recent volatility with discipline. While challenges remain, their large footprints, improving margins, and strategic cost reductions make them worth watching in April 2025. Investors looking for growth opportunities in U.S. cannabis may find value in these names as the industry begins its next phase of expansion.

The post Marijuana Stocks in Focus: U.S. Companies Ready for a Breakout appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The legal operators are now facing the reality of how Donald Trump’s tariffs will impact the cannabis industry. For the ancillary side of the cannabis industry, many products are made overseas. Places like China are deep into the cannabis industry. Some of the companies are known for manufacturing vaporizer parts and packaging solutions. Now with tariffs in place things that were once more affordable for cannabis consumers will ultimately go up in price.

However, how will this long-term impact legal operators as a business? Will the increase in goods hurt the market or lead to more profits? Are those who use cannabis going to look for cheaper products that fit their means and their budget? This is only the start as there is more to see. Another question is how will affect the public sector. Are the tariffs going to drop marijuana stocks further or will they bring in much-needed momentum?

At this time there are many unknowns as speculation on how to invest in cannabis stocks is still met with uncertainty. Some feel finding top marijuana stocks to buy now with how low the shares are is a good strategy for future gains. Especially with all that is going on across most niches in the public sector. Now is a good time to learn and keep an eye out for the best marijuana stocks to watch.

Top Marijuana Stocks To Follow In 2025

1. Glass House Brands Inc. (OTC:GLASF)
2. Planet 13 Holdings Inc. (OTC:PLNH)
3. FLUENT Corp. (OTC:CNTMF)

Glass House Brands Inc.

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

Recently, the company announced a collaboration with the University of California, Berkeley, to explore hemp-related research. This includes novel medicinal product development, identification, and improvement of hemp genetics. As well as market analysis, supply chain sustainability, and AI automation for cultivation and production.

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

On April 2nd the company announced the opening of a new dispensary in Orange Park, FL. This new location not only expands its operations but it helps to better serve the medical cannabis community in Jacksonville.

Words From The Company

“We’re thrilled to open another convenient Planet 13 dispensary, bringing our award-winning products to the growing Florida medical cannabis community,” said Bob Groesbeck, Co-CEO of Planet 13. “

[Read More] This Is How Marijuana Stocks May Be Impacted By Donald Trump’s Tariffs

FLUENT Corp.

FLUENT Corp., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. Recently, the company announced it has expanded the Hyer Kind brand to the NYC cannabis market.

Hyer Kind’s expertly crafted, live rosin-infused pre-rolls “Boosters” are now available at all adult-use FLUENT retail stores throughout New York.

[Read More] April 2025 Watchlist: Leading Cannabis Stocks from Canada

Words From The CEO

“We are thrilled to expand access to Hyer Kind products beyond Florida and now into New York,” said Robert Beasley, CEO of FLUENT. “As we grow our brand and product portfolio in New York, we remain committed to aligning our menu selection with Florida, ensuring consistency and familiarity for our patients and customers nationwide.”

The post This Is How The Tariffs Will Impact Marijuana Stocks In 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..